Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease

Hyun Jun Jung1, Eryn E Dixon2, Richard Coleman1

  • 1Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.

Physiological Genomics
|September 18, 2023
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) is linked to polycystin gene mutations. This study identifies a polycystin-2 (PC2) signaling pathway involving cilia, Wnt, and MAPK, revealing Glis3 downregulation as a key factor in cyst formation.

Area of Science:

  • Genetics
  • Molecular Biology
  • Nephrology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited kidney disorder.
  • Mutations in polycystin genes (Pkd1, Pkd2) cause ADPKD, but cystogenesis mechanisms remain unclear.
  • Understanding polycystin-2 (PC2) downstream effects is crucial for ADPKD research.

Purpose of the Study:

  • To identify genes and signaling pathways regulated by PC2.
  • To investigate the role of PC2 in initiating cyst formation in ADPKD.
  • To create a comprehensive gene expression database following PC2 depletion.

Main Methods:

  • Developed an inducible mouse inner medullary collecting duct cell line for conditional Pkd2 knockout.
  • Performed genome-wide transcriptome profiling using RNA sequencing after PC2 depletion.
  • Validated candidate cystogenic gene expression in Pkd2 knockout mice.

Main Results:

  • Nearly 900 genes showed altered expression upon PC2 depletion.
  • Differentially expressed genes were enriched in primary cilia, Wnt, and MAPK signaling pathways.
  • Downregulation of the transcription factor Glis3 and activation of Wnt/MAPK signaling were observed in Pkd2 knockout models.

Conclusions:

  • Identified a PC2-dependent cilia-to-nucleus signaling axis.
  • Dysregulation of Gli-similar transcription factors, including Glis3, may initiate ADPKD cyst formation.
  • The catalog of PC2-regulated genes offers resources for ADPKD research and drug development.